PIK3CA and breast cancer: Targeting phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) mutations with alpelisib in breast cancer and mutations of the tumour suppressor PTEN are typical examples.